Soleno Therapeutics (SLNO) Issues Earnings Results, Misses Estimates By $0.08 EPS

Soleno Therapeutics (NASDAQ:SLNO) issued its earnings results on Wednesday. The company reported ($0.17) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.09) by ($0.08), Bloomberg Earnings reports.

Soleno Therapeutics traded up $1.75, reaching $1.75, during trading on Thursday, according to MarketBeat.com. 34,500 shares of the stock were exchanged, compared to its average volume of 48,620. Soleno Therapeutics has a twelve month low of $1.76 and a twelve month high of $1.77.

In other news, major shareholder Larry N. Feinberg bought 50,000 shares of the stock in a transaction that occurred on Tuesday, May 15th. The shares were acquired at an average cost of $1.80 per share, for a total transaction of $90,000.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 69.75% of the stock is currently owned by insiders.

A number of equities analysts recently weighed in on SLNO shares. Maxim Group set a $4.00 target price on shares of Soleno Therapeutics and gave the stock a “buy” rating in a report on Wednesday. ValuEngine upgraded shares of Soleno Therapeutics from a “strong sell” rating to a “sell” rating in a report on Friday, February 2nd. Finally, Noble Financial set a $4.00 target price on shares of Soleno Therapeutics and gave the stock a “buy” rating in a report on Wednesday.

Soleno Therapeutics Company Profile

Soleno Therapeutics, Inc focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company's lead candidate, diazoxide choline controlled-release (DCCR), a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is entering into Phase II/III clinical development.

Earnings History for Soleno Therapeutics (NASDAQ:SLNO)

Receive News & Ratings for Soleno Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Soleno Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Rayonier Advanced Materials  to Issue Quarterly Dividend of $0.07
Rayonier Advanced Materials to Issue Quarterly Dividend of $0.07
First Trust Municipal High Income ETF  Declares $0.14 Monthly Dividend
First Trust Municipal High Income ETF Declares $0.14 Monthly Dividend
Hexcel  Holdings Cut by State Board of Administration of Florida Retirement System
Hexcel Holdings Cut by State Board of Administration of Florida Retirement System
Adient  Shares Sold by State Board of Administration of Florida Retirement System
Adient Shares Sold by State Board of Administration of Florida Retirement System
State Board of Administration of Florida Retirement System Sells 4,364 Shares of Royal Gold
State Board of Administration of Florida Retirement System Sells 4,364 Shares of Royal Gold
State Board of Administration of Florida Retirement System Sells 5,692 Shares of Reliance Steel & Aluminum Co
State Board of Administration of Florida Retirement System Sells 5,692 Shares of Reliance Steel & Aluminum Co


Leave a Reply

© 2006-2018 Ticker Report. Google+.